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Hydroxyproline (Hyp) analogues of bradykinin and lysyl-bradykinin, in which the third residue of bradykinin, proline, 
is replaced by hydroxyproline, were isolated from human urine. Their amino acid sequences were confirmed by both 
amino acid and sequence analyses, and also by comparison of their chromatographic behavior with that of synthetic 
peptides. The possibility that Lys-Alas-bradykinin, isolated by Mindroiu et al. [(1986) J. Biol. Chem. 261, 7407-74111 
from human urine, was actually Lys-Hyp’-bradykinin is discussed. 
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1. INTRODUCTION 
We have recently isolated and identified a 
hydroxyproline (Hyp) analogue of bradykinin 
(BK), Hyp’-BK, from the ascitic fluid of a patient 
with gastric cancer [l]. Sasaguri et al. [2] have also 
described the literature of a Hyp analogue of Lys- 
BK from human plasma proteins (possibly 
kininogens) by digestion with hog pancreatic 
kallikrein. ‘However, little is known concerning the 
functions of these new types of bradykinin. 
One of the physiological and pathological func- 
tions of kallikrein is to regulate renal blood flow 
by the intrarenally generated kinins. To under- 
stand the function of renal kallikrein fully, it is 
necessary to identify all kinins occurring in urine. 
Three kinds of kinin, i.e. BK, Lys-BK and Met- 
Lys-BK, have been detected thus far in human 
urine [3,4]. Furthermore, Mindroiu et al. [5] have 
recently reported the occurrence of a new kinin, 
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Lys-Ala3-BK, in human urine. We report here the 
isolation and identification of two kinins, 
Hyp3-BK and Lys-Hyp3-BK, from human urine 
and discuss the possibility that the Lys-Ala3-BK 
described by Mindroiu et al. was actually 
Lys-Hyp3-BK. 
2. MATERIALS AND METHODS 
Synthetic BK, Lys-BK and Lys-Hyp’-BK were purchased 
from the Peptide Institute (Osaka). Lys-Ala’-BK was a product 
of Peninsula Labs (Belmont, CA). Hyp”-BK was synthesized as 
in [l]. Sephadex G-25 superfine was purchased from Pharmacia 
(Japan). Urine, collected from healthy males who showed no 
abnormality in kidney function, was stored at - 20°C until use. 
Kinin was assayed by contraction of the estrous rat uterus using 
authentic BK as standard, as reported [6]. The amino acid com- 
position and sequence were determined with a Pica-Tag HPLC 
system (Waters Associates, Bedford, MA) and a gas-phase pro- 
tein sequencer (model 47OA) equipped with a 12OA PTH 
analyzer by the on-line system (Applied Biosystems. Foster 
City, CA) according to (11. PTH-hydroxyproline was identified 
from the two characteristic peaks of PTH-hydroxyproline 
stereoisomers on HPLC, as in [l]. Peptides were separated by 
reversed-phase HPLC with an ODS-12OA column (4.6 mm x 
25 cm) or a column (4.6 mm x 17 cm) of ODS-12OT from Toyo 
Soda (Tokyo), using a linear gradient of acetonitrile in 0.1% 
trifluoroacetic acid or by isocratic elution with 17% acetonitrile 
as reported in [I], and by ion-exchange chromatography with 
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an SP-5PW column (1 x 8 cm, Toyo Soda) with a linear NaCl 
gradient in 10 mM ammonium formate containing 10% 
acetonitrile and at a flow rate of 1 ml/min. 
Table 1 
Amino acid compositions of kinins isolated from human urine 
3. RESULTS 
The supernatant fraction of a mixture of 2 1 of 
the urine and 8 1 ethanol was concentrated in 
vacua and applied to a Sephadex G-25 colun (3 x 
90 cm), equilibrated with 10% acetic acid. Kinin 
activity was thereby eluted as a single peak. The 
kinin-containing fractions were pooled; lyophi- 
lized and subjected to reversed-phase HPLC with 
a linear gradient of acetonitrile in 0.1% trifluoro- 
acetic acid. Kinin activity was eluted at 30-35% 
acetonitrile. The kinin fractions were combined, 
lyophilized and further subjected to reversed-phase 
HPLC with isocratic elution of 17% acetonitrile. 
As shown in fig.lA, kinin activity was detected in 
three fractions designated I-III. The retention 
times of fractions I-III were identical with those 
of synthetic Lys-Hyp3-BK, Hyp3-BK (Lys-BK) and 
BK, respectively (see lower part of fig.lA). Upon 
further reversed-phase HPLC, fraction I gave a 
single peak (not shown). The identity of this frac- 
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Fig.1. (A) Reversed-phase HPLC of kinins from human urine 
(upper) and synthetic kinins (lower). Kinins were applied to a 
column (4.6 mm x 25 cm) of ODS-12OA and separated using 
an isocratic system. Shadedareas how the fractions with kinin 
activity. (1) Lys-Hyp’-BK, (2) Hyp’-BK, (3) Lys-BK, (4) BK 
and (5) Lys-Ala’-BK. (B) Ion-exchange chromatography of 
fraction II on a column (1 x 8 cm) of SP-SPW. Fraction II and 
a mixture of Hypj-BK (2) and Lys-BK (3) were applied 
separately to the column and separated by a linear NaCl 
gradient. 
Amino acid Fraction 
Hydroxyproline 
Serine 
Glycine 
Arginine 
Proline 
Phenylalanine 
Lysine 
I 
0.9 (1) 
1.1 (1) 
1.4 (1) 
1.8 (2) 
1.7 (2) 
1.8 (2) 
1.4 (1) 
IIa 
0.6 (1) 
1.1 (1) 
1.4 (1) 
2.0 (2) 
2.1 (2) 
2.0 (2) 
- 
IIb 
- 
1.3 (1) 
1.4 (1) 
2.1 (2) 
2.6 (3) 
2.0 (2) 
0.8 (1) 
tion with Lys-Hyp3-BK was confirmed from the 
amino acid composition (table 1) and also by the 
sequence analysis (fig.2). Fraction II was not yet 
homogeneous and could be separated into two 
peaks (IIa,IIb) by ion-exchange chromatography 
on an SP-SW column (fig.lB). The chromato- 
graphic behavior of fractions IIa and IIb was iden- 
tical with that of synthetic Hyp’-BK and Lys-BK, 
respectively. The homogeneity of fraction IIa was 
confirmed by further reversed-phase HPLC (not 
shown). Determination of amino acid composi- 
tions (table 1) and sequence analysis (fig.2) con- 
firmed that fractions IIa and IIb were actually 
Hyp’-BK and Lys-BK, respectively. The yields of 
Lys-Hyp3-BK, Hyp3-BK and Lys-BK from 2 1 of 
human urine (calculated from the recovery in 
amino acid sequence analysis) were 0.51, 0.18 and 
0.11 nmol, respectively. Fraction III was not fur- 
ther characterized ue to the low yield. However, 
its retention time on reversed-phase HPLC in- 
dicates that it is BK and not Lys-Ala3-BK (fig.1). 
Fraction IIa A&f E HJ$ u Phe Se5 G $" Aa 
49 86 27 54 56 53 43 39 12 
Fraction IIb L$ Ag Prq Pry G* Phe g Prq Phq Arq 
30 27 25 21 22 13 16 20 9 
Fig.2. Amino acid sequences of fractions I, IIa and IIb. Arrows 
indicate the PTH-amino acids assigned by the gas-phase 
sequencer. Values beneath arrows represent pmol PTH amino 
acid. 
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4. DISCUSSION 
The results reported above clearly indicate that 
human urine contains Hyp3-BK and Lys-Hyp3-BK 
in addition to Lys-BK and BK. Met-Lys-BK, which 
is known to be present in human urine, could not 
be detected in this study. Further work is still need- 
ed to elucidate the biological significance of the 
two Hyp analogues of BK. It should be noted in 
this connection that the yields of Lys-Hyp3-BK and 
Hyp3-BK from human urine were significantly 
higher than those of Lys-BK and BK. 
Although Mindroiu et al. [5] have reported the 
occurrence of Lys-Ala3-BK in human urine as a 
new kinin, we were unable to detect this type. To 
us it seems very likely that their kinin was not Lys- 
Ala3-BK but Lys-Hyp3-BK. The reasons for this 
argument are 4-fold. (i) Like our Lys-Hyp3-BK, 
their kinin was eiuted before Lys-BK on reversed- 
phase HPLC. (ii) Although they identified the 
fourth residue of their kinin as alanine, the 
presence of alanine in their preparation is not cer- 
tain, because the amino acid composition is not 
given. (iii) In HPLC one of the two PTH-Hyp 
stereoisomer peaks shows a retention time very 
similar to that of PTH-alanine [l]. (iv) Finally, 
synthetic Lys-Ala3-BK was eluted after Lys-BK, 
but not before Lys-BK as reported in their study. 
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